Research ArticleUnder the Microscope

Immune Disorders and Susceptibility to Neoplasms

Om Prakash, Javed Gill and Gist Farr
Ochsner Journal March 2002, 4 (2) 107-111;

References

  1. ↵
    1. Penn I.
    (1996) Neoplasia: an example of plasticity of the immune response. Transplant Proc 28:2089–2093, pmid:8769163.
    OpenUrlPubMed
  2. ↵
    1. Ensoli B.,
    2. Sturzl M.,
    3. Monini P.
    (2001) Reactivation and role of HHV-8 in Kaposi's sarcoma initiation. Adv Cancer Res 81:161–200, pmid:11430595.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Kestens L.,
    2. Melbye M.,
    3. Biggar R. J.
    (1985) Endemic African Kaposi's sarcoma is not associated with immunodeficiency. Int J Cancer 36:49–54, pmid:4018905.
    OpenUrlPubMedWeb of Science
  4. ↵
    1. Beral V.,
    2. Peterman T. A.,
    3. Berkelman R. L.
    (1990) Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 335:123–128, pmid:1967430.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Chang Y.,
    2. Cesarman E.,
    3. Pessin M. S.
    (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865–1869, pmid:7997879.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Prakash O.,
    2. Tang Z. Y.,
    3. He Y. E.
    (2000) Human Kaposi's sarcoma cell-mediated tumorigenesis in human immunodeficiency type 1 tat-expressing transgenic mice. J Natl Cancer Inst 92:721–728, pmid:10793108.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    1. Selik R. M.,
    2. Rabkin C. S.
    (1998) Cancer death rates associated with human immunodeficiency virus infection in the United States. J Natl Cancer Inst 90:1300–1302, pmid:9731737.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Swinnen L. J.
    (2000) Diagnosis and treatment of transplant-related lymphoma. Ann Oncol 11(Suppl 1):45–48, pmid:10707778.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Filipovich A. H.,
    2. Mathur A.,
    3. Kamat D.
    (1992) Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res 52(Suppl 19):5465s–5467s, pmid:1327508.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Knowles D. M.,
    2. Cesarman E.,
    3. Chadburn A.
    (1995) Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85:552–565, pmid:7812011.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Cesarman E.,
    2. Chadburn A.,
    3. Liu Y. F.
    (1998) BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome. Blood 92:2294–2302, pmid:9746767.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Riddler S. A.,
    2. Breinig M. C.,
    3. McKnight J. L.
    (1994) Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood 84:972–984, pmid:8043879.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Rooney C. M.,
    2. Smith C. A.,
    3. Ng C. Y.
    (1995) Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virusrelated lymphoproliferation. Lancet 345:9–13, pmid:7799740.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    1. Dazzi F.,
    2. Goldman J. M.
    (1998) Adoptive immunotherapy following allogeneic bone marrow transplantation. Annu Rev Med 49:329–340, pmid:9509267.
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    1. Grulich A. E.
    (1999) AIDS-associated non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 21(Suppl 1):S27–S30, pmid:10430215.
    OpenUrlPubMedWeb of Science
  16. ↵
    1. Cesarman E.,
    2. Chang Y.,
    3. Moore P. S.
    (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332:1186–1191, pmid:7700311.
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    1. Grierson H.,
    2. Purtilo D. T.
    (1987) Epstein-Barr virus infections in males with the X-linked lymphoproliferative syndrome. Ann Intern Med 106:538–545, pmid:3030174.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    1. Penn I.
    (1990) Cancers complicating organ transplantation. N Engl J Med 323:1767–1769, pmid:2247108.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Hojo M.,
    2. Morimoto T.,
    3. Maluccio M.
    (1999) Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 397:530–534, pmid:10028970.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Wilkinson A. H.,
    2. Smith J. L.,
    3. Hunsicker L. G.
    (1989) Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone. Transplantation 47:293–296, pmid:2645716.
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    1. Silman A. J.,
    2. Petrie J.,
    3. Hazleman B.
    (1988) Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20-year follow up study. Ann Rheum Dis 47:988–992, pmid:3207388.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Sokal E. M.,
    2. Antunes H.,
    3. Beguin C.
    (1997) Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus. Transplantation 64:1438–1442, pmid:9392308.
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    1. Swinnen L. J.,
    2. Costanzo-Nordin M. R.,
    3. Fisher S. G.
    (1990) Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 323:1723–1728, pmid:2100991.
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    1. Penn I.
    (1998) De novo malignances in pediatric organ transplant recipients. Pediatr Transplant 2:56–63, pmid:10084762.
    OpenUrlPubMed
  25. ↵
    1. Foster C. B.,
    2. Lehrnbecher T.,
    3. Samuels S.
    (2000) An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. Blood 96:2562–2567, pmid:11001912.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. International Collaboration on HIV and Cancer
    (2000) Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 92:1823–1830, pmid:11078759.
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    1. Wit F. W.,
    2. Sol C. J.,
    3. Renwick N.
    (1998) Regression of AIDS-related Kaposi's sarcoma associated with clearance of human herpesvirus-8 from peripheral blood mononuclear cells following initiation of antiretroviral therapy. AIDS 12:218–219, pmid:9468373.
    OpenUrlPubMedWeb of Science
  28. ↵
    1. Przybylski G. K.,
    2. Goldman J.,
    3. Ng V. L.
    (1996) Evidence for early B-cell activation preceding the development of Epstein-Barr virus-negative acquired immunodeficiency syndrome-related lymphoma. Blood 88:4620–4629, pmid:8977254.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    1. Righetti E.,
    2. Ballon G.,
    3. Ometto L.
    (2002) Dynamics of Epstein-Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy. AIDS 16:63–73, pmid:11741164.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section